tetano
Editor, Senior Moderator
Front Cell Infect Microbiol
. 2021 Dec 14;11:763687.
doi: 10.3389/fcimb.2021.763687. eCollection 2021.
Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines
Hardeep Singh Tuli[SUP] 1 [/SUP], Katrin Sak[SUP] 2 [/SUP], Poonam Aggarwal[SUP] 3 [/SUP], Ashif Iqubal[SUP] 4 [/SUP], Sushil K Upadhaya[SUP] 1 [/SUP], Jagjit Kaur[SUP] 5 [/SUP], Ginpreet Kaur[SUP] 6 [/SUP], Diwakar Aggarwal[SUP] 1 [/SUP]
Affiliations
Abstract
Within almost the last 2 years, the world has been shaken by the coronavirus disease 2019 (COVID-19) pandemic, which has affected the lives of all people. With nearly 4.92 million deaths by October 19, 2021, and serious health damages in millions of people, COVID-19 has been the most serious global challenge after the Second World War. Besides lost lives and long-term health problems, devastating impact on economics, education, and culture will probably leave a lasting impression on the future. Therefore, the actual extent of losses will become obvious only after years. Moreover, despite the availability of different vaccines and vaccination programs, it is still impossible to forecast what the next steps of the virus are or how near we are to the end of the pandemic. In this article, the route of molecular evolution of the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is thoroughly compiled, highlighting the changes that the virus has undergone during the last 2 years and discussing the approaches that the medical community has undertaken in the fight against virus-induced damages.
Keywords: COVID pandemic; molecular evolution; therapeutics; vaccination; variants.
. 2021 Dec 14;11:763687.
doi: 10.3389/fcimb.2021.763687. eCollection 2021.
Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines
Hardeep Singh Tuli[SUP] 1 [/SUP], Katrin Sak[SUP] 2 [/SUP], Poonam Aggarwal[SUP] 3 [/SUP], Ashif Iqubal[SUP] 4 [/SUP], Sushil K Upadhaya[SUP] 1 [/SUP], Jagjit Kaur[SUP] 5 [/SUP], Ginpreet Kaur[SUP] 6 [/SUP], Diwakar Aggarwal[SUP] 1 [/SUP]
Affiliations
- PMID: 34970505
- PMCID: PMC8712944
- DOI: 10.3389/fcimb.2021.763687
Abstract
Within almost the last 2 years, the world has been shaken by the coronavirus disease 2019 (COVID-19) pandemic, which has affected the lives of all people. With nearly 4.92 million deaths by October 19, 2021, and serious health damages in millions of people, COVID-19 has been the most serious global challenge after the Second World War. Besides lost lives and long-term health problems, devastating impact on economics, education, and culture will probably leave a lasting impression on the future. Therefore, the actual extent of losses will become obvious only after years. Moreover, despite the availability of different vaccines and vaccination programs, it is still impossible to forecast what the next steps of the virus are or how near we are to the end of the pandemic. In this article, the route of molecular evolution of the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is thoroughly compiled, highlighting the changes that the virus has undergone during the last 2 years and discussing the approaches that the medical community has undertaken in the fight against virus-induced damages.
Keywords: COVID pandemic; molecular evolution; therapeutics; vaccination; variants.